Skip to main content
Clinical Trials/NL-OMON20182
NL-OMON20182
Recruiting
Not Applicable

Diffusion-weighted whole-body imaging with background body signal suppression (DWIBS) for colorectal cancer screening.

niversity medical center, Utrecht, The NetherlandsProf. dr. Siersema, MD, PhDDepartment of Gastroenterology and HepatologyUniversity Medical Center UtrechtP.O. Box 85500, 3508 GA UtrechtHeidelberglaan 100, 3584 CX UtrechtTel.nr.: +31 88 7555555Fax.nr.: +31 88 755 5533E-mail: p.d.siersema@umcutrecht.nl0 sites390 target enrollmentTBD

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Colorectal cancer
Sponsor
niversity medical center, Utrecht, The NetherlandsProf. dr. Siersema, MD, PhDDepartment of Gastroenterology and HepatologyUniversity Medical Center UtrechtP.O. Box 85500, 3508 GA UtrechtHeidelberglaan 100, 3584 CX UtrechtTel.nr.: +31 88 7555555Fax.nr.: +31 88 755 5533E-mail: p.d.siersema@umcutrecht.nl
Enrollment
390
Status
Recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional

Investigators

Sponsor
niversity medical center, Utrecht, The NetherlandsProf. dr. Siersema, MD, PhDDepartment of Gastroenterology and HepatologyUniversity Medical Center UtrechtP.O. Box 85500, 3508 GA UtrechtHeidelberglaan 100, 3584 CX UtrechtTel.nr.: +31 88 7555555Fax.nr.: +31 88 755 5533E-mail: p.d.siersema@umcutrecht.nl

Eligibility Criteria

Inclusion Criteria

  • 1\. Age 50 years or older;
  • 2\. Patients who will undergo a colonoscopy because of the suspicion of having colorectal carcinoma, with at least one of the following symptoms: rectal blood loss, altered bowel habits, unexplained weight loss, abdominal pain, and/or anemia;

Exclusion Criteria

  • 1\. General contra\-indications for MRI (metal devices \[pacemakers, endoprotheses, intra uterine devices, neurostimulators, insulin pump, intra\-ocular parts of metal, ear implants, artificial metal cardial valves], claustrophobia);
  • 2\. Weight \>100kg;

Outcomes

Primary Outcomes

Not specified

Similar Trials